Craig Adam R
SEC-identified person · CIK 1339498 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| X4 Pharmaceuticals, Inc XFOR | Director · Executive Chairman | filed 2025 - 2025 |
| CTI Biopharma Corp ctic | Director · See Remarks | filed 2017 - 2023 |
| Viracta Therapeutics, Inc. VIRX | EVP, Development & CMO | filed 2012 - 2015 |
| Innovive Pharmaceuticals, Inc. NA | VP and Chief Medical Officer | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.